TBT BSN | Notification

Notification Detail :: G/TBT/N/BRA/1566

Notification No.

Notification Type

Notifying Member

Date of Notification

Final Date for Comments

Days to Final Date

Title

Draft resolution 1283, 19 September 2024

Objective

Protection of human health or safety (TBT)

Product Covered

Medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not in measured doses or put up for retail sale (excl. goods of heading 3002, 3005 or 3006) (HS code(s): 3003); Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. goods of heading 3002, 3005 or 3006) (HS code(s): 3004)

Document Notification

Link to ePing

HSCODE

3003 - Medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not in measured doses or put up for retail sale (excl. goods of heading 3002, 3005 or 3006); 3004 - Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. goods of heading 3002, 3005 or 3006)

ICSCODE

11.120 - Pharmaceutics

Keywords

Human health

Specific Regions

Description

This Draft Resolution contains provisions on the Good Pharmacovigilance Practices for Medicine Registration Holders for human use, to include the mandatory use of the WHODrug Dictionary to describe medicines when sending notifications.

Notified Document

1:File here

Link to Notification

EN:File here

FR:File here

ES:File here

Status Active

No	#	Comment By	Title	Comment Date	File

Back

Notification Detail :: G/TBT/N/BRA/1566

Link to ePing

App Settings